Jane Wasman
2016
In 2016, Jane Wasman earned a total compensation of $2M as President, International, General Counsel and Corporate Secretary at Acorda Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $312,077 |
| Option Awards | $627,121 |
| Salary | $555,100 |
| Stock Awards | $459,296 |
| Other | $7,950 |
| Total | $1,986,544 |
Wasman received $627.1K in option awards, accounting for 32% of the total pay in 2016.
Wasman also received $25K in bonus, $312.1K in non-equity incentive plan, $555.1K in salary, $459.3K in stock awards and $8K in other compensation.
Rankings
In 2016, Jane Wasman's compensation ranked 4,919th out of 14,075 executives tracked by ExecPay. In other words, Wasman earned more than 65.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,919 out of 14,075 | 65th |
Division Manufacturing | 1,751 out of 5,489 | 68th |
Major group Chemicals And Allied Products | 549 out of 1,895 | 71st |
Industry group Drugs | 405 out of 1,538 | 74th |
Industry Biological Products, Except Diagnostic Substances | 71 out of 279 | 75th |
Source: SEC filing on April 21, 2017.
Wasman's colleagues
We found five more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2016.
2016
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2016
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2016
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2016
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2016
David Lawrence
Acorda Therapeutics